Sera预测内幕人士出售股票,因为该公司报告的Q4收入低于预期水平。 Sera Prognostics insiders sold shares as the company reported lower-than-expected Q4 earnings.

一家妇女保健公司Sera预测公司最近看到一些内部人出售股票。 Sera Prognostics Inc., a women's health company, saw several insiders sell shares recently. CFO Austin Aerts公司和Joshua Phillips公司董事做了大量销售,降低了所有权。 CFO Austin Aerts and Director Joshua Phillips made significant sales, reducing their ownership. 该公司的Q4收入未达到预期,每股损失0.24美元,而估计为0.22美元。 The company's Q4 earnings missed expectations, with a loss of $0.24 per share versus estimates of $0.22. 机构投资者持有54.64%的股票。 Institutional investors hold 54.64% of the stock. Sera预测技术开发了PreTRM测试,这是预测自发早产的生物标志测试。 Sera Prognostics develops the PreTRM test, a biomarker test to predict spontaneous preterm birth.